市場調查報告書

閉塞球囊導管市場:成長,趨勢,預測(2020∼2025)

Occlusion Balloon Catheter Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 925292
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
閉塞球囊導管市場:成長,趨勢,預測(2020∼2025) Occlusion Balloon Catheter Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

心臟病的增加和老年人口的增加,是閉塞球囊導管市場成長的主要原因。預計與再加上導管技術的進步,末稍血管疾病的盛行率增加,更加推動市場成長。

再加上在預測期間內預計推動市場成長的政府及非官方機構的努力使心血管疾病相關意識高漲。譬如,National Heart,Lung,and Blood Institute、 美國的其他群組,以及每年慶祝National Red Day提高心臟病相關的意識。這樣的舉措,對這些已開發國家的市場成長有所貢獻。

但,血管成形術程序的高成本及熟練的工程師的不足,妨礙市場成長。

本報告提供全球閉塞球囊導管市場趨勢與今後材料,症狀,終端用戶,各地區的預測,與主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 老年人口的增加和心臟病的盛行率上升
    • 可支配所得和醫療保健費的增加
  • 市場阻礙因素
    • 導管治療的高成本
    • 熟練的工程師的不足和感染的風險
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場細分化

  • 各材料
    • 乳膠
    • 矽膠
    • 其他
  • 各症狀
    • 末稍血管疾病
    • 冠狀動脈疾病
    • 其他
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Boston Scientific Corp.
    • Cook Group Incorporated
    • Stryker Corporation
    • WL Gore & Associates.
    • Merit Medical Systems
    • Oscor, Inc.
    • Edwards Lifesciences Corporation
    • PRYTIME MEDICAL
    • Fuji Systems
    • Edwards Lifesciences Corporation
    • QXMedical

第7章 市場機會及未來趨勢

目錄
Product Code: 67819

Increasing cardiac diseases and the growing geriatric population are the primary factors for the growth of the occlusion balloon catheters market. Furthermore, increasing prevalence of peripheral vascular diseases coupled with advancements in catheterization technologies are projected to boost the market growth furthermore.

Moreover, the increasing awareness about cardiovascular diseases by the efforts of government and non-government organizations projected to boost the market growth over the forecast period. For instance, National Heart, Lung, and Blood Institute, along with the other groups around the United States, annually celebrate National Red Day, to raise the awareness about heart diseases. Such initiatives are contributing to the market growth in tehse developed countries.

However, the high cost of angioplasty procedures and the dearth of skilled professionals are hampering the market growth.

Key Market Trends

Coronary Artery Disease Application Projected to Grow at Notable Rate

  • According to the Center for Disease Control and Prevention (CDC), coronary artery disease was the most common type of heart disease killing around, 365,914 people in 2017 in the United States.
  • Furthermore, advancements in angioplasty coupled with the increasing prevalence of coronary artery disease rates are expected to boost the market growth.
  • Peripheral vascular disease segment is projected to have significant growth rate owing to an increase in peripheral vascular cases and the growing number of older population around the world.
  • For instance, according to the Institute for Health Metrics and Evaluation, Global Burden of Disease 2017, there was about 118.1 million prevalent cases and 10.8 million incident cases of peripheral artery disease worldwide in 2017.
  • Furthermore, the rising demand for minimally invasive procedures and technologically advanced interventions for better clinical outcome are anticipated to fuel the market growth over the forecast period.

North America Share Projected to Grow at Prominent Rates

North America is projected to have notable growth rate over the forecast period owing to the factors such as availability of large patient pool, rapid advancement in technologies and increasing healthcare spending. Furthermore, an increase in the prevalence of vascular diseases is expected to boost the regional share. According to the American Heart Association Heart Disease and Stroke Statistics 2019 Update, peripheral artery disease affects 8.5 million people nationwide.

The Asia Pacific is projected to have a significant growth rate owing to, changing lifestyle that leading to vascular diseases and developing healthcare infrastructure. Furthermore, a growing preference in minimally invasive surgeries and rapid development in healthcare spending in emerging countries such as India and China are expected to bolster the regional market growth in the near future.

Competitive Landscape

Occlusion balloon catheters market is moderately fragmented and the presence of more number of market players. Market players are actively focusing on new product development and product launches to expand the market share. For instance, in April 2017, QXMedical has launched ResQ Occlusion Balloon Catheter in the United States. The key players operating in the market are Boston Scientific Corp., Cook Group Incorporated, Stryker Corporation, W. L. Gore & Associates., and Oscor Inc. among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population and Rising Prevalence of Cardiac Diseases
    • 4.2.2 Increasing Disposable Income and Healthcare Spending
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Catheterization Procedures
    • 4.3.2 The Dearth of Skilled Professionals and Risk of Infection
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material
    • 5.1.1 Latex
    • 5.1.2 Silicone
    • 5.1.3 Others
  • 5.2 By Indication
    • 5.2.1 Peripheral Vascular Diseases
    • 5.2.2 Coronary Artery Diseases
    • 5.2.3 Others
  • 5.3 End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corp.
    • 6.1.2 Cook Group Incorporated
    • 6.1.3 Stryker Corporation
    • 6.1.4 W. L. Gore & Associates.
    • 6.1.5 Merit Medical Systems
    • 6.1.6 Oscor, Inc.
    • 6.1.7 Edwards Lifesciences Corporation
    • 6.1.8 PRYTIME MEDICAL
    • 6.1.9 Fuji Systems
    • 6.1.10 Edwards Lifesciences Corporation
    • 6.1.11 QXMedical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS